The global Artificial Intelligence Discovers Molecules market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

AI discovery of molecules is the use of machine learning tools to explore large databases containing known molecules and their properties. Using this information can generate new possibilities to discover new drug candidates faster and at a lower cost.

As an important force driving a new round of scientific and technological revolution, artificial intelligence has been of national strategic importance. Many governments introduce policies and increase capital investment to support AI companies. The Digital Europe plan adopted by the European Union will allocate €9.2 billion on high-tech investments, such as supercomputing, artificial intelligence, and network security. In order to maintain its leading position, the United States will increase its investment in artificial intelligence research and development in non-defense fields, from US$1.6 billion to US$1.7 billion in 2022. According to the latest data released by IDC, global artificial intelligence revenue was US$432.8 billion in 2022, a year-on-year increase of 19.113%, including software, hardware, and services.

ReportPrime's newest research report, the “Artificial Intelligence Discovers Molecules Industry Forecast” looks at past sales and reviews total world Artificial Intelligence Discovers Molecules sales in 2024, providing a comprehensive analysis by region and market sector of projected Artificial Intelligence Discovers Molecules sales for 2025 through 2031. With Artificial Intelligence Discovers Molecules sales broken down by region, market sector, and sub-sector, this report provides a detailed analysis in US$ millions of the world Artificial Intelligence Discovers Molecules industry.

This Insight Report provides a comprehensive analysis of the global Artificial Intelligence Discovers Molecules landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Artificial Intelligence Discovers Molecules portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Artificial Intelligence Discovers Molecules market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Artificial Intelligence Discovers Molecules and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Artificial Intelligence Discovers Molecules.

This report presents a comprehensive overview, market shares, and growth opportunities of Artificial Intelligence Discovers Molecules market by product type, application, key players, and key regions and countries.

• Drug Design and Synthesis
• Drug Prediction
• Other

• Tumor
• Central Nervous System
• Other

• Americas
• APAC
• Europe
• Middle East & Africa

• Insilico Medicine
• Verge Genomics
• IBM Watson Health
• Exscientia
• BenevolentAI
• Atomwise
• Cloud Pharmaceutical
• Numerate
• OWKIN
• AccutarBio
• XtalPi
• Deep intelligent